Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDIFAST INCMED · Entity 6587 | Director | October 01, 2020 | October 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDIFAST INC
Report date October 01, 2020 · Filed October 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 266,179 |
Ending reported balance
After 2020-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2020-10-01 · Sale · Disposed 177 · Balance 271,002 F1: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.02 to $163.86, inclusive. Row 2 · 2020-10-01 · Sale · Disposed 1,232 · Balance 269,770 F1: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to 164.99, inclusive. Row 3 · 2020-10-01 · Sale · Disposed 2,784 · Balance 266,986 F1: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.01 to 165.99, inclusive. Row 4 · 2020-10-01 · Sale · Disposed 624 · Balance 266,362 F1: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.00 to $166.89, inclusive. Row 5 · 2020-10-01 · Sale · Disposed 183 · Balance 266,179 F1: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.07 to $167.21, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.02 to $163.86, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to 164.99, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.01 to 165.99, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.00 to $166.89, inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.07 to $167.21, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2020 Filed Oct 2, 2020 21:30 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 183 | $167.13 | $30,584.79 |
DisclosureSEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 5 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,179 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.07 to $167.21, inclusive. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:30 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 624 | $166.39 | $103,827.36 |
DisclosureSEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 4 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,362 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.00 to $166.89, inclusive. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:30 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 2,784 | $165.49 | $460,724.16 |
DisclosureSEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 3 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,986 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.01 to 165.99, inclusive. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:30 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,232 | $164.62 | $202,811.84 |
DisclosureSEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,770 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to 164.99, inclusive. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:30 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 177 | $163.40 | $28,921.80 |
DisclosureSEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,002 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.02 to $163.86, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 560 | $142.35 | $79,716.00 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 9 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,179 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.62, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 584 | $141.58 | $82,682.72 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 8 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,739 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.00 to $141.99, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 343 | $140.64 | $48,239.52 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 7 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,323 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.26 to $140.97, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 985 | $139.47 | $137,377.95 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 6 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,666 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.00 to $139.98, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 628 | $138.55 | $87,009.40 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 5 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,651 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.08 to $138.99, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 457 | $137.25 | $62,723.25 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 4 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,279 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.00 to $137.78, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,001 | $136.62 | $136,756.62 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 3 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,736 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.00 to 136.99, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 241 | $135.45 | $32,643.45 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,737 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.01 to 135.99, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 201 | $134.70 | $27,074.70 |
DisclosureSEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,978 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.38 to $134.82, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 19, 2020 00:39 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-074830 · tm2022977d4_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,179 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,800 | $91.42 | $164,556.00 |
DisclosureSEC source: 0001104659-20-058953 · tm2019159d2_4.xml · nonDerivative · entry 6 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,096 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $92.00, inclusive. Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 3,200 | $90.35 | $289,120.00 |
DisclosureSEC source: 0001104659-20-058953 · tm2019159d2_4.xml · nonDerivative · entry 5 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,896 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.98, inclusive. Read SEC document |
| January 02, 2020 Filed May 8, 2020 23:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,448 | $112.31 | $162,624.88 |
DisclosureSEC source: 0001104659-20-058953 · tm2019159d2_4.xml · nonDerivative · entry 4 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,096 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.02 to $112.83, inclusive. Read SEC document |
| January 02, 2020 Filed May 8, 2020 23:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 2,412 | $111.62 | $269,227.44 |
DisclosureSEC source: 0001104659-20-058953 · tm2019159d2_4.xml · nonDerivative · entry 3 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,544 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.96, inclusive. Read SEC document |
| January 02, 2020 Filed May 8, 2020 23:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 500 | $110.52 | $55,260.00 |
DisclosureSEC source: 0001104659-20-058953 · tm2019159d2_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,956 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.21 to $110.79, inclusive. Read SEC document |
| January 02, 2020 Filed May 8, 2020 23:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 640 | $109.40 | $70,016.00 |
DisclosureSEC source: 0001104659-20-058953 · tm2019159d2_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,456 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.12 to $109.99, inclusive. Read SEC document |
| May 16, 2019 Filed May 28, 2019 22:22 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 9,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-028487 · tv522589_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 9,800 F1 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| May 16, 2019 Filed May 28, 2019 22:22 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 9,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-028487 · tv522589_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,096 Read SEC document |
| April 10, 2019 Filed Apr 12, 2019 22:00 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 1,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-019562 · tv518881_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,896 Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 200 | $133.30 | $26,660.00 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 8 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,071 F9 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.02 to $133.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,371 | $132.56 | $181,739.76 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 7 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,271 F8 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.02 to $132.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,200 | $131.44 | $157,728.00 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 6 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,642 F7 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.00 to $131.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 3,654 | $130.39 | $476,445.06 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 5 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,842 F6 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.005 to $130.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 500 | $133.34 | $66,670.00 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 4 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 0 F5 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.03 to $133.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. F2 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 2,883 | $132.58 | $382,228.14 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 3 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 500 F4 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.02 to $132.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. F2 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 2,410 | $131.46 | $316,818.60 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 3,383 F3 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.02 to $131.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. F2 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 01:52 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 6,607 | $130.38 | $861,420.66 |
DisclosureSEC source: 0001144204-19-012829 · tv515784_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 5,793 F1 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. F2 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:00 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-010327 · tv514784_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,496 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 03, 2018 Filed Feb 16, 2019 00:41 UTC Amendment | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-008734 · tv513987_5a.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 12,400 F2 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| December 03, 2018 Filed Feb 16, 2019 00:41 UTC Amendment | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-008734 · tv513987_5a.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,788 F1 · shares: This transaction was inadvertently omitted from the reporting person's original Form 5. Read SEC document |
| November 08, 2018 Filed Feb 15, 2019 02:52 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 4,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-008526 · tv513898_5.xml · nonDerivative · entry 4 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 9,900 F1 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Feb 15, 2019 02:52 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 4,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-008526 · tv513898_5.xml · nonDerivative · entry 3 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,288 Read SEC document |
| October 29, 2018 Filed Feb 15, 2019 02:52 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 5,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-008526 · tv513898_5.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Michael C. MacDonald Charitable Remainder Unitrust Disclosed balance after: 5,843 F1 · ownership.nature: The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein. Read SEC document |
| October 29, 2018 Filed Feb 15, 2019 02:52 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 5,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-008526 · tv513898_5.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,345 Read SEC document |
| March 09, 2018 Filed Mar 14, 2018 00:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 20,000 | $88.96 | $1,779,200.00 |
DisclosureSEC source: 0001144204-18-014456 · tv488456_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,188 Read SEC document |
| March 08, 2018 Filed Mar 14, 2018 00:03 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 20,000 | $84.45 | $1,689,000.00 |
DisclosureSEC source: 0001144204-18-014456 · tv488456_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,188 Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 23:22 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-007044 · tv485454_form4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,188 F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2019. Read SEC document |
| December 31, 2017 Filed Feb 9, 2018 23:22 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 15,200 | $69.81 | $1,061,112.00 |
DisclosureSEC source: 0001144204-18-007044 · tv485454_form4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,908 Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 00:59 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 8,000 | $45.07 | $360,560.00 |
DisclosureSEC source: 0001144204-17-010270 · v460108_4.xml · nonDerivative · entry 3 MACDONALD MICHAEL C · CIK 0001207400 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,108 Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:59 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 15,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010270 · v460108_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,108 F2 · shares: This one time retention stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest annually in equal installments over a period of three years, beginning on the first anniversary of the grant date. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:59 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 38,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010270 · v460108_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,488 F1 · shares: Represents shares issued to the reporting person under the 2012 Share Incentive Plan after pre-established performance -based conditions were satisfied for the 2016 performance period. Read SEC document |
| January 02, 2017 Filed Jan 4, 2017 21:10 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 8,000 | $41.63 | $333,040.00 |
DisclosureSEC source: 0001144204-17-000580 · v456230_4.xml · nonDerivative · entry 2 MACDONALD MICHAEL C · CIK 0001207400 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,488 Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:10 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 9,000 | $41.63 | $374,670.00 |
DisclosureSEC source: 0001144204-17-000580 · v456230_4.xml · nonDerivative · entry 1 MACDONALD MICHAEL C · CIK 0001207400 · Director · Exec Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,488 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.